<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0022">
 <label>22</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Abouzid</surname>
    <given-names>KA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Khalil</surname>
    <given-names>NA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ahmed</surname>
    <given-names>EM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Mohamed</surname>
    <given-names>KO.</given-names>
   </name>
  </person-group>
  <article-title>[(3-[(6-Arylamino)pyridazinylamino]benzoic acids: design, synthesis and in vitro evaluation of anticancer activity</article-title>. 
  <source>Arch Pharm Res</source>
  <year>2013</year>;
  <volume>36</volume>:
  <fpage>41</fpage>–
  <lpage>50</lpage>.
  <pub-id pub-id-type="pmid">23307426</pub-id>
 </mixed-citation>
</ref>
